-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
April 01, 2013 - life.6 Treatment safety is defined by the total rates of
adverse effects and adverse effects that lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_consumer.pdf
July 01, 2017 - Having high cholesterol levels and high blood pressure can increase the risk of
CV disease and could lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
November 01, 2016 - » Eye problems and possibly blindness
» Nerve damage
» Foot problems, which in severe cases may
lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer-2016.pdf
January 01, 2016 - » Eye problems and possibly blindness
» Nerve damage
» Foot problems, which in severe cases may
lead
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
February 01, 2014 - surgical repair compared to late surgical repair (i.e.,
nonoperative intervention followed by surgery) lead … • Key question # 4: Does operative repair compared with nonoperative treatment lead to
improved … Cycle 1 (1st assessment)
In total, 9 experts (6 CER-specific: lead author, clinical content experts … For larger tears (>1 cm), double-
row repair methods lead to
significantly lower retear rates
when … Does operative repair compared with nonoperative treatment lead to improved health-related quality of
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - presence of uncertainty.5 Uncertainty about the
most appropriate way to define drug exposure can
lead … This result can lead either to insight into potential
unaddressed bias or confounding, or it could be … time
can be summarized, and differences in the time
window during which exposure is determined
can lead … For example, an outcome
definition of all cardiovascular events including
angina could lead to a different … oversampling of cases exposed
to one of the drugs under study (or, similarly, an
undersampling) can lead
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - measured in the administrative claims data (smoking, obesity,
aspirin use, education, and income) would lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 29, 2011
EPC Protocol – Version 8 – 12.22.10
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Treatment for Phenylketonuria
Amen…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
July 01, 2012 - This is the case primarily because most treatments lead directly to the
intended result (or to adverse … add-on, triage
Desciption of index test performance and
interpretation; how results of index test lead … strategy
Desciption of comparator test performance
and interpretation; how results of comparator
test lead
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
January 01, 2012 - increase in short-term expenditures
that PET requires, but some experts noted that early detection might lead
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-krishnan.pdf
August 27, 2012 - Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing research
Slide 1
Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing
research
August 27, 2012
Jerry A. Krishnan, MD, PhD (jakris@uic.edu)
Professor of Medicine and Public Health
Associate V…
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - This
may lead to different outcomes among treatment centers. … MSCs are purported to lead to the
regeneration of cartilage due to either the secretion of growth factors … However, the mechanism by which
these cells lead to cartilage generation is still unclear.
1
MSCs … The experts
thought that tofacitinib could improve health outcomes in patients with RA and might lead … the specialist office to primary care offices, which
might allow for earlier treatment, but could lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
September 20, 2013 - low risk of bias or inconsistencies
among groups of studies at different levels of risk of bias will lead … tests are often referred to as tests for publication bias, reasons other than publication bias can lead … methodological
search
filters
to
identify
diagnostic
accuracy
studies
can
lead … following team members will be involved:
• The EPC Director
• The EPC Codirector
• One Project Lead … • One Coproject Lead/Research Associate
• Two Research Associates
• One Project Manager
• One Program
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - dose plus another lipid lowering drug have demonstrated that this “add on”
combination therapy can lead … In our view, LDL lowering
does not seem to lead to decreased clinical risk – would be extrapolating … dose plus another lipid lowering drug
have demonstrated that this “add on” combination therapy can lead … , it really has nothing to do with the
current topic
Table I on page 32:
COMMENT: Fibrates can lead … These trials have demonstrated that this “add on” combination
therapy can lead to superior lipid outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - This may lead to different outcomes among treatment
centers. … MSCs are purported to lead to cartilage regeneration because of the secretion of
growth factors by … However, the mechanism by which
these cells lead to cartilage generation is still unclear.
1
MSCs … that PRP injections might not have a durable response and that a need for repeated
injections could lead … The experts thought that tofacitinib could improve health outcomes in
patients with RA and might lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-quality-improvement_research-protocol.pdf
August 17, 2011 - Key Questions for Objective 2
Question 3
Does public reporting lead to change in health care … Question 4
Does public reporting lead to change in the behavior of patients, their representatives … Change is an intermediate outcome included in KQ 3, as it is not a given that all change
will lead … However, this
change in delivery may or may not necessarily lead to improvement in quality of care—
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0652-131114.pdf
May 15, 2013 - Topic 0533 Postpartum Hemorrhage NSD FINALsj
Postpartum Hemorrhage
Nomination Summary Document
Results of Topic Selection Process & Next Steps …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - Effective Health Care
Topic Number: 0142
Document Completion Date: 7-15-09
1
Results of Topic Selection Process & Next Steps
Noninvasive diagnosis of coronary artery disease in women will be developed as a systematic review
by the Effective Health Care (EHC) Program.
When key questi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - Genetic variants of the CYP2C19 locus can
affect the encoded protein: some lead to normal enzymatic … activity (denoted as CYP2C19*1 alleles,
corresponding to a normal metabolizer phenotype), while others lead … and *4, all loss-of-function alleles corresponding to a
nonmetabolizer phenotype), and still others lead … often referred to as a test for publication
bias; however, reasons other than publication bias can lead … with no enzymatic activity (corresponding to a nonmetabolizer
phenotype), and still other variants lead
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
September 01, 2021 - • Lead migration occurred in 14 to 24 percent of patients (2 trials, N=224), serious
device-related … Evidence on harms was
limited, but lead migration was common following occipital nerve stimulation placement